New Oral Drug Study
ChemoCentryx to Initiate Clinical Studies of CCR2 Antagonist CCX915
Investigational New Drug Application on File – Studies to Commence by Year End
{Background information first:
ChemoCentryx to Initiate Clinical Studies of CCR2 Antagonist CCX915
Investigational New Drug Application on File – Studies to Commence by Year End
{Background information first:
Scientists Observe How a Close Bond Activates the Immune System
The immune system is highly complex. The cast of characters alone required to marshal an immune response to a foreign invader can number in the millions as the body’s soldiers, T cells, are called into action. What triggers this complex response begins when T cells and dendritic cells {another type… read more »
Program Description
When Vince Macaluso was a med student he experienced visual disturbances that turned out to be multiple sclerosis. Now he is both a patient and
A new pathway for treating multiple sclerosis may have been found, if “exciting” results in mice can be replicated in humans.
Researchers trying a novel therapy on a mouse version of MS report that the mice showed “almost no inflammation of the myelin sheath and no nerve damage”. Furthermore, MS is characterised by periods of remission and relapse, but the
“Adequate Vitamin D Status Appears More Important than High Calcium Intake for Maintaining Calcium Metabolism”
MULTIPLE SCLEROSIS MS DIAGNOSIS MRIDescription - An international panel of neurologists has updated the current guidelines for diagnosing multiple sclerosis (MS), strengthening the role of magnetic resonance imaging (MRI). The guidelines, published online November 10, 2005 in the Annals of Neurology, update the “McDonald criteria,” created five years ago and named after the chair of the previous panel, Prof W. Ian McDonald of… read more »
OBJECTIVE: